Evidence map›Paper›PMID 20410378›Full record

ArticleMolecular & cellular proteomics : MCP2011

Enhanced sensitivity for selected reaction monitoring mass spectrometry-based targeted proteomics using a dual stage electrodynamic ion funnel interface.

Mahmud Hossain, David T Kaleta, Errol W Robinson, Tao Liu, Rui Zhao, Jason S Page, Ryan T Kelly, Ronald J Moore, Keqi Tang, David G Camp and 2 more

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Developments in FTICR-MS and Its Potential for Body Fluid Signatures.International journal of molecular sciences · 2015
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Protein target quantification decision tree.International journal of proteomics · 2013
    Article
  17. The proteomics big challenge for biomarkers and new drug-targets discovery.International journal of molecular sciences · 2012
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mahmud HossainBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, USA.
David T Kaleta
Errol W Robinson
Tao Liu
Rui Zhao
Jason S Page
Ryan T Kelly
Ronald J Moore
Keqi Tang
David G Camp
Wei-Jun Qian
Richard D Smith

Funding

WORKSHOP AND TRAINING ACTIVITIESP41RR018522 · NCRR · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2003 to 2011
$25.1M
A Universal Multiplex Assay System for High-Throughput Clinical ApplicationsDP2OD006668 · OD · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI QIAN, WEI-JUN · 2009 to 2009
$2.1M
NCRR NIH HHS P41 RR018522NCRR NIH HHS RR018522NIH HHS 1-DP2OD006668-01NIH HHS DP2 OD006668
6 · The paper itself

Abstract

Selected reaction monitoring mass spectrometry (SRM-MS) is playing an increasing role in quantitative proteomics and biomarker discovery studies as a method for high throughput candidate quantification and verification. Although SRM-MS offers advantages in sensitivity and quantification compared with other MS-based techniques, current SRM technologies are still challenged by detection and quantification of low abundance proteins (e.g. present at ∼10 ng/ml or lower levels in blood plasma). Here we report enhanced detection sensitivity and reproducibility for SRM-based targeted proteomics by coupling a nanospray ionization multicapillary inlet/dual electrodynamic ion funnel interface to a commercial triple quadrupole mass spectrometer. Because of the increased efficiency in ion transmission, significant enhancements in overall signal intensities and improved limits of detection were observed with the new interface compared with the original interface for SRM measurements of tryptic peptides from proteins spiked into non-depleted mouse plasma over a range of concentrations. Overall, average SRM peak intensities were increased by ∼70-fold. The average level of detection for peptides also improved by ∼10-fold with notably improved reproducibility of peptide measurements as indicated by the reduced coefficients of variance. The ability to detect proteins ranging from 40 to 80 ng/ml within mouse plasma was demonstrated for all spiked proteins without the application of front-end immunoaffinity depletion and fractionation. This significant improvement in detection sensitivity for low abundance proteins in complex matrices is expected to enhance a broad range of SRM-MS applications including targeted protein and metabolite validation.

Indexed as

AnimalsBiomarkersCattleChickensCytochromes cEscherichia coliHorsesMass SpectrometryMiceMuscle, SkeletalMyoglobinOvalbuminPeptidesProteomicsTrypsinBiomarkersCytochromes cMyoglobinOvalbuminPeptidesTrypsin

Identifiers

PMID20410378
PMCPMC3033664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.